Quantification and assessment of viability of Cryptococcus neoformans by LightCycler amplification of capsule gene mRNA

Journal of Medical Microbiology

Volumn 53, Issue 12, 2004, Pages 1201-1206

  Amjad, Muhammad ^a   Kfoury, Najla ^a   Cha, Raymond ^a,b   Mobarak, Reem ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; MESSENGER RNA; PLASMID VECTOR;

AGAR GEL ELECTROPHORESIS; ANALYTIC METHOD; ARTICLE; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CRYPTOCOCCUS NEOFORMANS; EXON; FUNGAL DETECTION; FUNGAL GENE; FUNGAL MENINGITIS; FUNGUS CULTURE; GENE AMPLIFICATION; HEAT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; ULTRAVIOLET RADIATION; YEAST CELL;

CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; MYCOLOGICAL TYPING TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, FUNGAL; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 11144240566     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45742-0     Document Type: Article

References (30)

1. Abadi, J., Nachman, S., Kressel, A. B. & Pirofski, L. (1999). Cryptococcosis in children with AIDS. Clin Infect Dis 28, 309-313.
2. Bialek, R., Weiss, M., Bekure-Nemariam, K., Najvar, L. K., Alberdi, M. B., Graybill, J. R. & Reischl, U. (2002). Detection of Cryptococcus neoformans DNA in tissue samples by nested and real-time PCR assays. Clin Diagn Lab Immunol 9, 461-469.
3. Blevins, L. B., Fenn, J., Segal, H., Newcomb-Gayman, P. & Carroll, K. C. (1995). False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol 33, 1674-1675.
4. Buchanan, K. L. & Murphy, J. W. (1998). What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 4, 71-83.
5. Bustin, S. A. (2000). Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25, 169-193.
6. Bustin, S. A. (2002). Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29, 23-39.
7. Chang, Y. C. & Kwon-Chung, K. J. (1999). Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol 181, 5636-5643.
8. Frade, J. P., Warnock, D. W. & Arthington-Skaggs, B. A. (2004). Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization. J Clin Microbiol 42, 2085-2093.
9. Franzot, S. P., Salkin, I. F. & Casadevall, A. (1999). Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 37, 838-840.
10. Gade, W., Hinnefeld, S. W., Babcock, L. S., Gilligan, P., Kelly, W., Wait, K., Greer, D., Pinilla, M. & Kaplan, R. L. (1991). Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J Clin Microbiol 29, 1616-1619.
11. Garcia-Hermoso, D., Janbon, G. & Dromer, F. (1999). Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 37, 3204-3209.
12. Gelmini, S., Tricarico, C., Petrone, L., Forti, G., Amorosi, A., Dedola, G. L., Serio, M., Pazzagli, M. & Orlando, C. (2003). Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate. Clin Chem Lab Med 41, 261-265.
13. Goldman, D. L., Khine, H., Abadi, J., Lindenberg, D. J., Pirofski, L., Niang, R. & Casadevall, A. (2001). Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107, E66.
14. Kaucner, C. & Stinear, T. (1998). Sensitive and rapid detection of viable Giardia cysts and Cryptosporidium parvum oocysts in large-volume water samples with wound fiberglass cartridge filters and reverse transcription-PCR. Appl Environ Microbiol 64, 1743-1749.
15. Kralovic, S. M. & Rhodes, J. C. (1998). Utility of routine testing of bronchoalveolar lavage fluid for cryptococcal antigen. J Clin Microbiol 36, 3088-3089.
16. Kwon-Chung, K. J. & Bennett, J. E. (1984). Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 120, 123-130.
17. Luo, G. & Mitchell, T. G. (2002). Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol 40, 2860-2865.
18. Maher, N. H., Vermund, S. H., Welsh, D. A., Dillon, H. K., Awooda, A. & Unnasch, T. R. (2001). Development and characterization of a molecular viability assay for Pneumocystis carinii f sp hominis. J Infect Dis 183, 1825-1827.
19. Mitchell, T. G., Freedman, E. Z., White, T. J. & Taylor, J. W. (1994). Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans. J Clin Microbiol 32, 253-255.
20. Miyoshi, Y., Ando, A., Takamura, Y., Taguchi, T., Tamaki, Y. & Noguchi, S. (2002). Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues. Int J Cancer 97, 129-132.
21. Okeke, C. N., Tsuboi, R., Kawai, M., Yamazaki, M., Reangchainam, S. & Ogawa, H. (2000). Reverse transcription - 3′ rapid amplification of cDNA ends-nested PCR of ACT1 and SAP2 mRNA as a means of detecting viable Candida albicans in an in vitro cutaneous candidiasis model. J Invest Dermatol 114, 95-100.
22. Okeke, C. N., Tsuboi, R. & Ogawa, H. (2001). Quantification of Candida albicans actin mRNA by the LightCycler system as a means of assessing viability in a model of cutaneous candidiasis. J Clin Microbiol 39, 3491-3494.
23. Peters, I. R., Helps, C. R., Hall, E. J. & Day, M. J. (2004). Real-time RT-PCR: considerations for efficient and sensitive assay design. J Immunol Methods 286, 203-217.
24. Prariyachatigul, C., Chaiprasert, A., Meevootisom, V. & Pattanakitsakul, S. (1996). Assessment of a PCR technique for the detection and identification of Cryptococcus neoformans. J Med Vet Mycol 34, 251-258.
25. Rappelli, P., Are, R., Casu, G., Fiori, P. L., Cappuccinelli, P. & Aceti, A. (1998). Development of a nested PCR for detection of Cryptococcus neoformans in cerebrospinal fluid. J Clin Microbiol 36, 3438-3440.
26. Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D. & Dismukes, W. E. (2000). Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 30, 710-718.
27. Stordeur, P., Poulin, L. F., Craciun, L., Zhou, L., Schandene, L., de Lavareille, A., Goriely, S. & Goldman, M. (2002). Cytokine mRNA quantification by real-time PCR. J Immunol Methods 259, 55-64.
28. Tanaka, K., Miyazaki, T., Maesaki, S. & 7 other authors (1996). Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis. J Clin Microbiol 34, 2826-2828.
29. Tintelnot, K., Adler, S., Bergmann, F., Schonherr, K. & Seibold, M. (2000). Case reports. Disseminated cryptococcoses without cryptococcal antigen detection. Mycoses 43, 203-207.
30. Warren, N. G. & Hazen, K. C. (1999). Candida, Cryptococcus, and other yeasts of medical importance. In Manual of Clinical Microbiology, pp. 1184-1200, 7th edn. Edited by P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover & R. H. Yolken. Washington, DC: American Society for Microbiology.